Mesial temporal lobe epilepsy (mTLE) is the most common form of epilepsy, believed to arise in part from compromised GABAergic inhibition. The neuronal specific K + /Cl − co-transporter 2 (KCC2) is a critical determinant of the efficacy of GABAergic inhibition and deficits in its activity are observed in mTLE patients and animal models of epilepsy. To test if reductions of KCC2 activity directly contribute to the pathophysiology of mTLE, we locally ablated KCC2 expression in a subset of principal neurons within the adult hippocampus. Deletion of KCC2 resulted in compromised GABAergic inhibition and the development of spontaneous, recurrent generalized seizures. Moreover, local ablation of KCC2 activity resulted in hippocampal sclerosis, a key pathological change seen in mTLE. Collectively, our results demonstrate that local deficits in KCC2 activity within the hippocampus are sufficient to precipitate mTLE.
Introduction
Mesial temporal lobe epilepsy (mTLE) is the most common form of human epilepsy, classified by unprovoked, spontaneous seizures originating within the temporal lobe. mTLE in humans develops over a latent period of several years after a precipitating insult such as traumatic brain injury, hypoxia, infection, or episodes of status epilepticus [1, 2] . In addition to seizures, profound morphological changes are observed in the brain, the most common being hippocampal sclerosis [3] . Sclerotic hippocampal tissue surgically removed from human mTLE patients shows widespread neuronal loss and gliosis [4] . Similar changes are seen in convulsant-induced rodent models of mTLE [5] .
While the cellular mechanisms that underlie the development of mTLE remain poorly understood, deficits in the efficacy of γ-aminobutyric acid (GABA) mediated inhibitory neurotransmission are widely believed to be of significance [6] [7] [8] . Fast synaptic inhibitory transmission in the brain is primarily mediated by chloride (Cl − )-permeable γ-aminobutyric acid receptors (GABA A Rs), which upon opening hyperpolarize the cell membrane through Cl − influx and decrease neuronal firing. During development, the electroneutral K + /Cl − co-transporter 2 (KCC2) becomes the dominant mediator of Cl − extrusion, coupling Cl − efflux to the outwardly directed K + gradient [9, 10] . Deficits in KCC2-mediated Cl − extrusion result in increased intracellular Cl − levels, permitting depolarizing GABA A R responses [11] . KCC2 loss-of-function mutations in human patients result in severe cases of epilepsy in infancy with migrating focal seizures [12, 13] . In mice, a global loss of 95% of KCC2 results in seizures and mortality at 2-3 weeks postnatal [14] , and loss-of-function mutations increase seizure susceptibility [15, 16] . Reduced KCC2 levels and depolarizing GABA A R signaling are observed in tissue surgically removed from mTLE patients [17] [18] [19] [20] . In rodent models of mTLE, reduced KCC2 is observed in the hippocampus immediately after an initial precipitating injury and during subsequent epileptogenesis [21] [22] [23] [24] [25] . However, it is unknown if these deficits directly contribute to the development of seizures and accompanying pathophysiology of mTLE.
To test this, we have ablated KCC2 expression in a subset of principal neurons in the hippocampus of adult mice. We show that reducing KCC2 activity leads to increased neuronal Cl − accumulation and gross deficits in GABAergic inhibition. Moreover, these deficits are sufficient to initiate recurring generalized seizures, reactive astrogliosis, and neuronal loss within the hippocampus, reproducing the core features of mTLE with hippocampal sclerosis. Thus, local inhibition of KCC2 within the hippocampus is sufficient to precipitate mTLE. EBioMedicine 32 (2018) 62-71
Materials and Methods

Animal Care
Animal studies were performed with protocols approved by the Institutional Animal Care and Use Committee of Tufts Medical Center. Mice were kept on a 12-h light/dark cycle with ad libitum access to food and water.
Generation and Genotyping of KCC2
FL Mice KCC2 FL mice (Slc12a5 lox/lox ) were have been described previous and have been backcrossed on the C57BL/6 J mice for 10 generations [26] . PCR was with an expected product size of 426 bp for wild-type and 543 bp for KCC2 FL mice.
Viral Injections
Adult (6-8 week old) male KCC2 FL mice were stereotaxically injected with adeno-associated virus (AAV) containing Cre recombinase. Prior to surgery, mice were injected with buprenorphine (0.75 mg/kg, s.c.) and anesthetized with isoflurane (1-3%). Drill holes were made above each dorsal hippocampus (coordinates: AP -2.0 mm from bregma, ML +/− 1.8 mm) and a Neuros syringe (Hamilton, Reno, NV) lowered to 2.0 mm below the brain surface. Mice were bilaterally injected with 0.5 μL of either AAV9·CaMKII·HI.eGFP-Cre.WPRE. SV40 or AAV9·CaMKII0.4.eGFP·WPRE.rBG (titer: 1 × 10 13 GC/mL in PBS, University of Pennsylvania Vector Core, Philadelphia, PA) at a rate of 50 nL/min. After injection, the needle remained in the brain 5 min before being withdrawn. The skin was closed and mice placed on a heating pad until mobile. Mice were singly housed post-surgery.
EEG/EMG and Video Recordings
A subset of virus-injected mice were implanted with electroencephalography/electromyography (EEG/EMG) headstages (2-channel, Pinnacle Technology, Lawrence, KA) following virus injection. Implants were aligned with lambda and 4 screws inserted for subdural recording contacts above the right frontal and parietal lobes. The implant was glued to the skull and mice recovered as above. After a recovery period of 7 days, continuous paired video and EEG/EMG recordings were collected using Sirenia Acquisition software (Pinnacle). Recordings were processed using Sirenia Seizure (Pinnacle) and EEG seizure events detected using DClamp (Massachusetts General Hospital Pediatric Epilepsy Research Lab, Boston, MA). Seizure FFT spectra were created using MATLAB (Mathworks, Natick, MA).
Slice Immunohistochemistry
Mouse brains were fixed by transcardial perfusion of PBS-buffered 4% paraformaldehyde (PFA) (Electron Microscopy Services, Hatfield, PA) and removed to 4% PFA overnight, then cryoprotected in 30% sucrose solution in PBS for 3 days before being frozen in optimal cutting temperature medium (VWR, Radnor, PA). 40 μm serial coronal sections were prepared using a Leica SM-2000R microtome (Wetzlar, Germany). Sections were kept at −20°C in cryoprotectant solution (876 mM sucrose, 4 M polyvinylpyrrolidone, 30% ethylene glycol, and 10% PBS in diH 2 O), and washed with PBS before blocking. Sections were blocked with 10% normal goat serum (NGS) and 0.3% Triton X-100 in PBS for 2 h at room temperature. Sections were incubated overnight with either anti-KCC2 C-terminus (1:500 rabbit, Millipore 07-432, Darmstadt, Germany), anti-GFAP (1:5000 mouse, Millipore MAB360), or antiNeuN (1:1000 mouse, Millipore MAB377). Slices were subsequently labeled with Alexa-Fluor secondary antibodies (1:200; Thermo Fisher Scientific, Waltham, MA) prior to mounting with ProLong Gold with or without DAPI (Thermo Fisher). To measure KCC2 expression levels Z-stack images were taken of the hippocampus at 20× using an Eclipse Ti confocal microscope (Nikon, Tokyo, Japan). Regions of interest (ROI) were drawn in the CA1 or DG and the average intensity for each ROI was normalized to the maximum average intensity per animal. Slices of each animal were averaged and compared between groups at equivalent time-points after virus injection. For NeuN, images were taken at 60× of CA1 principal layer or dentate gyrus granule cell layer, and 100 μm 2 ROIs drawn. NeuN positive labeled cells were counted in each ROI, averaged for each animal and compared between groups. For GFAP labeling, images were obtained using a scanning fluorescence microscope (BZ-X700, Keyence, Osaka, Japan) at 10x magnification. ROIs were drawn around the CA1 or DG in each slice. A threshold was used create a binary mask of GFAP labeling, and area calculated for ROI and reported as amount of GFAP labeling/mm 2 . Values from each animal were averaged and then compared between groups. All image processing was performed using FIJI (ImageJ).
Slice Electrophysiology
Mice were anesthetized with isofluorane and brains removed. Coronal slices (350 μm) were cut on a Leica VT1000s vibratome in ice-cold cutting solution containing (in mM): 87 NaCl, 2.5 KCl, 0.5 CaCl 2 , 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 7 MgCl 2 , 50 sucrose and 25 glucose, pH 7.4. Slices were placed in a submerged chamber for a 1 h recovery period at 32°C in artificial cerebrospinal fluid (aCSF) containing (in mM): 126 NaCl, 26 NaHCO 3 , 2.5 KCl, 2 MgCl 2 , 2 CaCl 2 , 1 glutamine, 1.25 NaH 2 PO 4 , 1.5 Na-pyruvate and 10 glucose. All solutions were bubbled with 95% O 2 /5% CO 2 . Gramicidin Perforated Patch Recordings. After a 1-h recovery, slices were placed in a submerged chamber (RC-27 L, Warner Instruments, Hamden, CT). For perforated patch, micropipettes (3-4 MΩ) contained saline (in mM): 140 KCl and 10 HEPES, pH 7.4 KOH, and were backfilled with gramicidin D (50 μg/mL, Sigma Aldrich) to establish access resistances between 20 and 80 MΩ throughout the recording period. Dentate gyrus granule cells were patched in the outer 2/3 of the granule cell layer to avoid newborn granule cells. A glass pipette (1-3 MΩ tip resistance) filled with muscimol (10 μM, Tocris Bioscience, Bristol, UK) in aCSF was lowered into the molecular layer of the dentate gyrus and pulses (500 ms) applied locally by pressure ejection with a Picospritzer II (General Valve, Fairfield, NJ) to activate GABA A -mediated currents in granule cells held at voltages between −100 to −50 mV in 10-mV increments. E GABA values were obtained from linear regression fits to the data at voltages near the observable reversal potential of I muscimol . Tetrodotoxin (TTX, 400 nM, Tocris) was applied to block activity-dependent shifts in E GABA and bumetanide (10 μM, Tocris) to inhibit NKCC1, and VU0463271 to inhibit KCC2 (1 μM, AstraZeneca, Cambridge, UK). Voltages were corrected offline with a liquid junction potential value of 3.8 mV. Recordings were performed with a Multiclamp 700B amplifier and Clampex 10 acquisition software. Data were low-pass filtered at 10 kHz and analyzed offline with Clampfit (Molecular Devices, Sunnyvale, CA).
Primary Neuron Culture
Primary cortical/hippocampal neurons were prepared and cultured as previously described [27] . Briefly, P0 KCC2 FL mice were anesthetized on ice and the brains removed. The brains were dissected in Hank's buffered salt solution (HBSS, Invitrogen) with 10 mM HEPES. The cortices and hippocampi were tripsinized and triturated to dissociate the neurons. Cells were counted using a hemocytometer and plated on poly-L-lysine-coated coverslips (for ICC and electrophysiology) or in 35 mm dishes (for immunoblot) at a density of 1 × 10 5 or 4 × 10 5 cells respectively. At days in vitro (DIV) 18, cells were exposed to control or Cre AAV as described above at a concentration of 1 × 10 6 GC/mL. To determine effect on neuronal viability, GFP-positive cells were counted at DIV 24.
Immunocytochemistry
Immunocytochemistry (ICC) was carried out as previously described [28] . Briefly, primary cultured neurons were washed with PBS, fixed in 4% PFA in PBS, and permeabilized with 0.1% Triton X-100 in PBS. The cells were then blocked in a solution containing 5% BSA and 5% goat serum. Primary and secondary antibodies (as described above) were prepared at a dilution of 1:1000 in block solution and incubated with the cells for 1 h at room temperature in the dark. The cells were washed in PBS and mounted using ProLong Gold.
Immunoblotting
Immunoblotting was carried out as previously described [29] . Briefly, proteins were isolated in RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate and 1% Triton X-100, pH 7.4) and quantified using a Bradford assay (Bio-Rad, Hercules, CA, USA). Samples were prepared in sample buffer and 20 μg of protein was loaded onto a 7% (for KCC2) or 10% (for α-tubulin) polyacrylamide gel. Proteins were separated by sodium dodecyl sulfate poly-acrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membrane. Membranes were blocked in 5% milk in tris-buffered saline 1% Tween-20 (TBS-T) and incubated with primary antibodies anti-KCC2 C-terminus (1:1000 rabbit, Millipore 07-432), anti-KCC2 N-terminus (1:1000 rabbit, LS-C135150, LifeSpan Biosciences, Seattle, WA) or α-tubulin (1:5000 mouse, Sigma-Aldrich) for 1 h. The membranes were washed and incubated for 1 h at room temperature with HRPconjugated secondary antibodies (1:5000 -Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Protein bands were visualized with Pierce ECL (ThermoFisher) and imaged using a ChemiDoc MP (Bio-Rad).
Culture Electrophysiology
Neurons were recorded at 33°C in saline containing (in mM) 140 NaCl, 2.5 KCl, 2.5 MgCl 2 , 2.5 CaCl 2 , 10 HEPES, 11 glucose, pH 7.4 (NaOH). All solutions were applied through a three-barrel microperfusion apparatus (700 μm, Warner Instruments, Hampden, CT), and conducted in the presence of tetrodotoxin (300 nM) and bumetanide (10 μM) to block voltage-dependent sodium channels and NKCC1, respectively. Cells infected with control-or Cre-containing virus were selected by epifluorescence for GFP expression. Data were acquired using Clampex 10 software at an acquisition rate of 10 kHz with an Axopatch 2B amplifier and digitized with a Digidata 1440 (Molecular Devices). To detect endogenous Cl − levels, cells were perforated with gramicidin (50 mg/mL) dissolved in an internal pipette containing (in mM) 140 KCl, 10 HEPES, pH 7.4 (KOH) and a tip resistance of 3-4 MΩ. Following perforation to below a series resistance of 100 MΩ, E GABA values were found by application of muscimol (1 μM) during positive-going voltage ramps (20 mV/s).
Statistical Analysis
Statistical analysis was performed with GraphPad 7 (San Diego, CA) and R. Unpaired Student's t-tests were used unless otherwise indicated. Data were expressed as mean ± SEM, with significance set at α = 0.05.
Results
Deletion of KCC2 in Cultured Hippocampal Neurons Increases Neuronal Cl-Levels and Compromises GABAergic Inhibition
We have recently developed mice in which KCC2 expression can be inactivated via Cre-recombinase mediated excision of exons 22-25 in the respective gene SCN12A5. The deleted regions encodes the C-terminal amino acids 911-1096 (KCC2 FL Fig. 1A ). These residues have been established to play an essential role in transporter activity [30, 31] .
To assess the efficacy of this approach cultured neurons from the KCC2 FL mice were infected with adeno-associated viruses expressing fluorescent GFP and Cre recombinase under the control of the CaMKIIα promoter (AAV9-CaMKII-eGFP-Cre; AAV-Cre) to restrict expression of the respective transgene to principal neurons [32] . 18-DIV hippocampal cultures prepared from KCC2 FL homozygotes were infected with AAVCre or a similar virus construct containing GFP (AAV9-CaMKII-eGFP; AAV-GFP) and 3-6 days later detergent solubilized lysates were subjected to immunoblotting with antibodies that recognize the C or N- terminus of KCC2. Consistent with recombination, immunoreactivity of the C-terminal antibody, which recognizes epitopes within 911-1096, was dramatically reduced in neurons infected with AAV-Cre but not those infected with AAV-GFP. Parallel reductions in immunoreactivity were also seen with an antibody that recognizes the N-terminus of KCC2 (Fig. 1B) . Immunocytochemistry labeling confirmed the reduction of KCC2 (Fig. 1C ) Thus, deletion of residues 911-1096 leads to reduced steady state accumulation of KCC2.
To assess if the Cre-induced deficits in KCC2 expression impact chloride homeostasis, we performed gramicidin perforated patch recordings on cultured neurons 4 days after AAV infection. We measured E GABA by calculating the reversal potential of leak-subtracted muscimol (1 μM; a GABA A R agonist) currents during positive-directed voltage ramps. To isolate the role of KCC2 in setting E GABA , we performed these recordings in the presence of the NKCC1 inhibitor bumetanide (10 μM) and blocked neuronal activity with TTX (500 nM) to prevent activitydependent Cl − accumulation. KCC2 FL neurons infected with AAV-Cre had a positive shift in E GABA compared with those infected with AAV-GFP ( Fig. 1D-F ; AAV-GFP = −104 ± 3 mV, n = 11, AAV-Cre = −86 ± 2 mV, p b 0.001, n = 15). Collectively these studies in culture suggest that deletion of residues 911-1096 within KCC2 decreases KCC2 expression levels, and elevated levels of intracellular Cl 
Viral Infection Results in Local Deficits of KCC2 Expression in the Hippocampus of KCC2 FL Mice
To test the significance of our in vitro measurements, AAV-Cre or AAV-GFP were bilaterally injected into the hippocampus of 6-8 wk. old KCC2 FL mice (Fig. 2A) . The effects of viral infection on KCC2 expression levels was then examined 7-28 days after injection using immunohistochemistry coupled with confocal microscopy. GFP expression was evident in the hippocampus of KCC2 FL mice injected with either virus with robust endogenous fluorescence being seen in the CA1 and dentate gyrus (DG; Fig. 2A, B) . 100× Z-stack images taken at 21 days post showed loss KCC2 in GFP positive neurons, from mice infected with AAV-Cre (Fig. 2C) . In the AAV-Cre injected mice, GFP positive neurons with deficits in KCC2 expression were found adjacent to non-infected neurons which exhibited high levels of KCC2 staining. To provide quantitative information on expression levels, KCC2 immunoreactivity was measured in defined regions of interest (ROI) within CA1 and dentate gyrus (DG) of mice 7, 14, 21 or 28 days post virus. Steady state accumulation of KCC2 was observed significantly reduced in both CA1 and DG in AAV-Cre compared with AAV-GFP using an antibody recognizing an epitope within the C-terminus (Measured as percent of AAV-GFP controls, CA1: 7-day: 99.4 ± 11.9% p = 0.9597, 14-day: 95.8 ± 9.7% p = 0.6827, 21-day: 28.6 ± 3.6% p b 0.0001, 28-day: 56.8 ± 0.7% p b 0.0001, AAV-Cre DG: 7-day: 99.3 ± 7.7% p = 0.933, 14-day: 53.4 ± 16.1% p = 0.044, 21-day: 40.6 ± 9.9% p = 0.0038, 28-day: 47.8 ± 5.9% p = 0.0009). Thus, our viral strategy results in focal and specific deficits in KCC2 expression levels within the hippocampus.
Reducing KCC2 Expression in the Hippocampus Leads to Elevations in Neuronal Cl-Levels and Deficits in GABAergic Inhibition
To assess the effects of reducing KCC2 expression on GABA A R signaling, we prepared acute hippocampal slices from mice 14-17 days after virus infection. Perforated patch clamp recordings were performed on dentate gyrus granule cells (DGGCs) which exhibited GFP fluorescence. A puffer pipette containing muscimol (10 μM) was placed in the molecular layer to elicit GABA A R mediated currents (Fig. 3A) . The NKCC1 inhibitor bumetanide was applied to inhibit the contribution of NKCC1 and the voltage-gated sodium channel inhibitor TTX to block activity dependent shifts in Cl − . Steady state GABA A R-mediated currents were then measured at several holding potentials and this data used to determine E GABA . DGGCs infected with AAV-Cre showed more positive E GABA values compared to those infected with AAV-GFP ( Fig. 3B ; AAV-GFP = −94 ± 3 mV, AAV-Cre = −59 ± 7 mV, p = 0.002, n = 6). In I = 0 recordings, 5 of 6 AAV-Cre infected DGGCs exhibited depolarizing membrane potential responses to muscimol, while only 1 of 6 AAV-GFP infected DGGCs showed a depolarizing response. Subtracting V M from E GABA values showed that AAV-Cre infection flipped the GABA A R driving force (DF GABA ) from negative to positive values ( Fig. 3C ; DF GABA AAV-GFP = −12 ± 4 mV, DF GABA AAV-Cre = 18 ± 10 mV, p = 0.021, n = 6).
To further analyze Cl − extrusion, we assessed the effects of the KCC2 inhibitor VU0463271 (1 μM) on E GABA over a 15 min time course for DGGCs held at −70 mV [11, 33] . In DGGCs infected with AAV-GFP, muscimol-activated currents became progressively smaller but were unaffected in those infected with AAV-Cre (Fig. 3D) . E GABA was then determined at 15 min of treatment with VU0463271 infected neurons (AAV-GFP = −69 ± 5 mV, AAV-Cre = −57 ± 4 mV n = 5-6, p = 0.1025). ΔE GABA was found as the difference between pre and post VU0463271 E GABA values. This parameter exhibited a significant positive shift in AAV-GFP compared to those infected with AAV-Cre ( Fig. 3E ; AAV-GFP = 25 ± 6 mV, AAV-Cre = 2 ± 4 mV, p = 0.010, n = 5-6). Finally, there was no difference in resting membrane potential between the two groups (AAV-GFP = −83 ± 5 mV; AAV-Cre = −82 ± 8 mV, p = 0.914, n = 6). Thus, reducing KCC2 expression levels in the dentate gyrus leads to increased neuronal Cl − accumulation and the appearance of depolarizing GABA A R currents, hallmarks of compromised GABAergic inhibition.
KCC2 FL Mice Infected with AAV-Cre Develop Spontaneous Seizures
To assess the significance of reducing KCC2 activity on the development of epilepsy, KCC2 FL mice were subject to continuous EEG/EMG and video recording for up to 21 days after injection of AAVs. 2-channel EEG recordings were processed using DClamp Software, and generalized (Fig. 4D) . Seizure events had a mean duration of 54.4 ± 2.9 s (Fig. 4E) . Thus, focally reducing KCC2 expression in the hippocampus is sufficient to induce spontaneous, generalized seizures.
KCC2 FL Mice Infected With AAV-Cre Develop Gliosis and Neuronal Loss
In addition to spontaneous seizures, mTLE is characterized by profound hippocampal changes which include increased gliosis and decreased neuronal number [3, 34] . Therefore, we assessed if reducing KCC2 activity in the hippocampus has any effects on these parameters. We first stained brain sections from infected mice with antibodies against glial fibrillary acidic protein (GFAP), the expression of which is dramatically increased in reactive astrocytes [35] . Slices visualized using confocal microscopy and low power images revealed a dramatic increase in GFAP immunoreactivity in the hippocampus of mice injected with AAV-Cre but not those with AAV-GFP (Fig. 5A) . To provide quantitative information we compared GFAP immunoreactivity in CA1 or DG of mice 21 days after infection. Increased GFAP staining was evident in the CA1 of mice infected with AAV-Cre relative to AAV-GFP ( Fig. 5C ; AAV-GFP = 17,750 ± 7192 GFAP+ pixels/mm 2 , AAV-Cre = 149,777 ± 40,908 GFAP+ pixels/mm 2 , n = 3 mice, p = 0.0336). Similar increase in GFAP levels were seen in the DG; ( Fig. 5D ; AAV-GFP = 17,728 ± 6962 GFAP+ pixels/mm To further explore the relationship between KCC2 activity and neuronal viability we assessed the effects of reducing KCC2 expression in neuronal culture. To do so, cultured neurons from KCC2 FL mice were infected with AAV-Cre or AAV-GFP at 18 Div. The number of GFP positive cells was then compared 6 days later. The number of GFP expressing neurons was significantly reduced in cultures infected with AAV-Cre compared to AAV-GFP (Fig. 7 AAV-GFP: 17 ± 1 neurons/frame, AAVCre: 8 ± 1 neurons/frame, p b 0.0001, n = 12 frames taken from 3 coverslips for each virus treatment). Thus, KCC2 expression per-se appears to be a determinant of mature neuronal viability in this reduced preparation.
Collectively these results suggest that in addition to precipitating spontaneous seizures, decreasing KCC2 levels in the hippocampus leads to gliosis throughout the hippocampus and neuronal loss in CA1. Moreover, our studies in neuronal culture suggest that decreasing KCC2 is sufficient to decrease neuronal viability.
Discussion
The mechanisms that underlie the development of mesial temporal lobe epilepsy (mTLE) are poorly understood. It is generally accepted that deficits in the efficacy of GABAergic inhibition are of significance [7] . Fast synaptic inhibition is critically dependent upon neuronal hyperpolarization caused by Cl − influx, and accordingly deficits in KCC2
are seen in humans and animal models of epilepsy. Here we have addressed if focally reducing KCC2 in adult mouse hippocampus directly contributes to the development of the underlying pathophysiology of mTLE. Using stereotaxic injection, we locally infected the hippocampus of KCC2 FL mice with AAV virus expressing Cre under the control of the CaMKIIα promoter, facilitating specific recombination and KCC2 deletion in pyramidal neurons [32] . To validate our approach, we first infected cultured hippocampal neurons from KCC2 FL mice and showed through immunoblotting that 18 DIV Cre-expressing neurons displayed gross decreases in the expression levels of KCC2 compared to Cre-negative controls. In parallel, gramicidin perforated patch experiments demonstrated that E GABA was positively shifted reflecting increased Cl − accumulation.
Our results suggest that deletion of the C-terminus of native expressed KCC2 leads to its degradation, and parallel deficits in KCC2 activity.
To assess if our studies in culture translated to similar events in the brain, we introduced AAVs into the hippocampus of 6-8-week-old KCC2 FL mice using stereotaxic injection. We then examined viral infection using immunofluorescence up to several weeks after infection. GFP expression was evident within the hippocampus shortly after injection. The expression levels of KCC2 were then compared between GFPCre and GFP-Cre-negative control injected mice. Time dependent reductions in KCC2 expression were only evident in GFP-Cre expressing mice and seen in both CA1 and the DG. In keeping with these reductions in KCC2 expression, significant positive shifts in E GABA were recorded in GFP-Cre but not GFP-Cre-negative DG cells 14-17 days post virus injection. Furthermore, these E GABA shifts resulted in a switch from hyperpolarizing to depolarizing GABA A R currents. The role that KCC2 activity plays in regulating neuronal Cl-accumulation in the brain has recently been questioned by a recent publication suggesting that neuronal Cllevels are determined by impermeant anions within the extracellular matrix [36] . However, our results strongly suggest that KCC2 activity is critical in setting E GABA and the efficacy of fast GABAergic inhibition in cultured hippocampal neurons and in acute brain slices.
Computational modeling has suggested that reducing the efficacy of KCC2 mediated Cl − transport in a subset of pyramidal neurons increases the probability of seizure-like events [37] . To directly test this hypothesis in vivo, we performed continuous paired EEG and video recordings on KCC2 FL mice with induced focal deficits in KCC2 in the hippocampus.
All mice infected with GFP-Cre developed spontaneous, generalized seizures that recurred sporadically over the entire duration of our recordings. We observed no seizures in mice infected with GFP-Cre-negative. Thus, our results suggest that compromising KCC2 expression within subset of pyramidal neurons in the hippocampus is sufficient to induce epilepsy. Consistent with our results, deficits in KCC2 activity have been widely reported in convulsant-induced animal models of epilepsy in rodents prior to the onset of generalized seizures [21, 23] , and in brain tissue surgically removed from refractory mTLE patients [17] [18] [19] [20] . Our results support that deficits in KCC2 activity within pyramidal neurons of mature neuronal networks is a likely contributing factor to the initiation of epileptiform activity. Central to the progression and pathophysiology of mTLE is the observation of hippocampal sclerosis (HS), which is reproduced in animal models [34, 38, 39] . Thus, we assessed in parallel with the appearance of spontaneous seizures if focal deletion of KCC2 in the hippocampus leads to sclerosis. Significantly, the critical hallmarks of sclerosis-reduced neuronal number and enhanced gliosis-were seen in the hippocampus of KCC2 FL mice expressing GFP-Cre but not GFP alone. It is interesting to note that deletion of KCC2 appeared to selectively induce neuronal loss in CA1 compared to the DG. Similar preferential losses of CA1 neurons are seen in humans with mTLE [41] , but the underlying mechanisms of the increased susceptibility of this region to neuronal loss remain to be explored. Consistent with our experiments in whole animals, Cremediated deletion of KCC2 was sufficient to reduce neuronal viability of cultured KCC2 FL neurons. These findings support a former study that showed that decreasing KCC2 levels in mature neuronal culture using shRNA decreases neuronal viability [42] . Our results are the first experiment in vivo to show that ablating KCC2 in subsets of neurons results in decreased neuronal viability. In summary, our results suggest that locally compromising KCC2 activity within the hippocampus is sufficient to reproduce the core physiological and anatomical deficits associated with mesial temporal lobe epilepsy with hippocampal sclerosis, including spontaneous, recurring seizures, neuronal loss and gliosis. Thus, agents that potentiate KCC2 activity may be useful in treating mTLE.
Supplementary data to this article can be found online at https://doi. org/10.1016/j.ebiom.2018.05.029.
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Research in Context
Mesial temporal lobe epilepsy (mTLE) is the most common form of human epilepsy and arises largely due to deficits in the strength of inhibitory neurotransmission, a process that is in part dependent upon the neuron specific K + /Cl − co-transporter KCC2. To directly test the role KCC2 plays in mTLE we have used genetic manipulation to reduce its activity in subsets of neurons in the mouse hippocampus.
Reducing KCC2 activity compromised neuronal inhibition and was sufficient to precipitate mTLE. Collectively these results suggest that deficits in KCC2 activity directly contribute to the development of mTLE. Thus, agents that elevate KCC2 activity may be useful treatments for mTLE.
